Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cells

BMC Cell Biology

Volumn 9, Issue , 2009, Pages

  Tanaka, Marcelo N ^a   Diaz, Bruno L ^b   de Souza, Wanderley ^b   Morgado Diaz, Jose A ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL JUNCTIONAL COMPLEX PROTEIN; CELL PROTEIN; CLAUDIN 1; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1 RECEPTOR; PROSTAGLANDIN E2; PROSTANOID; PROTEIN KINASE C; RUTHENIUM RED; UNCLASSIFIED DRUG;

APICAL JUNCTIONAL COMPLEX; ARTICLE; CELL ADHESION; CELL STRAIN CACO 2; CELL STRUCTURE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; PERMEABILITY BARRIER; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 61849127337     PISSN: None     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-9-63     Document Type: Article

References (47)

1. Madara JL: Regulation of the movement of solutes across tight junctions. Annu Ver Physiol 1998, 60:143-159. 10.1146/annurev.physiol.60.1.143
2. Mitic LL Anderson JM: Molecular architecture of tight junctions. Annu Rev Physiol 1998, 60:121-142. 10.1146/annurev.physiol.60.1.121 9558457
3. Anderson JM Van Itallie CM Fanning AS: Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 2004, 16(2):140-145. 10.1016/j.ceb.2004.01.005 15196556
4. Jamora C Fuchs E: Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002, 4(4):E101-108. 10.1038/ncb0402-e101 11944044
5. Balda MS Matter K: Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol 2003, 13:310-318. 10.1016/ S0962-8924(03)00105-3 12791297
6. Behrens J: CadheriRs and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999, 18(1):15-30. 10.1023/ A:1006200102166 10505543
7. González-Mariscal L Tapia R Chamorro D: Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008, 1778(3):729-756. 10.1016/j.bbamem.2007.08.018 17950242
8. Itoh M Furuse M Morita K Kubota K Saitou M Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999, 147(6):1351-1363. 2168087 10601346 10.1083/jcb.147.6.1351
9. Balda MS Matter K: The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000, 19:2024-2033. 305688 10790369 10.1093/emboj/19.9.2024
10. Hata AN Breyer RM: Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation. Pharmacol Ther 2004, 103(2):147-166. 10.1016/j.pharmthera.2004.06.003 15369681
11. Shao J Lee SB Guo H Evers BM Sheng H: Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 2003, 63(17):5218-5223. 14500348
12. Han C Michalopoulos GK Wu T: Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 2006, 207(1):261-270. 10.1002/jcp.20560 16331686
13. Pai R Soreghan B Szabo IL Pavelka M Baatar D Tarnawski AS: Prostaglandin E2 transactivates EGF receptor: A novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med Mar 2002, 8(3):289-293. 10.1038/nm0302-289
14. Yoshimoto T Takahashi Y Kinoshita T Sakashita T Inoue H Tanabe T: Growth stimulation and epidermal growth factor receptor induction in cyclooxygenase-overexpressing human colon carcinoma cells. Adv Exp Med Biol 2002, 507:403-407. 12664617
15. Barbosa LA Goto-Silva L Redondo PA Oliveira S Montesano G De Souza W Morgado-Díaz JM: TPAAinduced signal transduction: a link between PKC and EGFR signaling modulates the assembly of intercellular junctions in Caco-2 cells. Cell Tissue Res 2003, 312:319 -331. 10.1007/ s00441-003-0727-z 12733059
16. Buchanan FG Wang D Bargiacchi F DuBois RN: Prostaglandin E2 regulates cell migration via intracellular activation of the epidermal growth factor receptor. J Biol Chem 2003, 278(37):35451-35457. 10.1074/ jbc.M302474200 12824187
17. Krause W DuBois RN: Eicosanoids and the large intestine. Prostaglandins Other Lipid Mediat 2000, 61(3-4):145-161. 10.1016/S0090-6980(00)00069-1 10867126
18. Honda A Sugimoto Y Namba T Watabe A Irie A Negishi M Narumia S Ichikawa A: Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J Biol Chem 1993, 268:7759-7762. 8385118
19. Kitamura T Itoh M Noda T Tani K Kobayashi M Maruyama T Kobayashi K Ohuchida S Sugimura T Wakabayashi K: Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci 2003, 94(7):618-621. 10.1111/j.1349-7006.2003.tb01492.x 12841871
20. Hawcroft G Ko CW Hull MA: Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells. Oncogene 2007, 26(21):3006-3019. 10.1038/sj.onc.1210113 17130837
21. Shoji Y Takahashi M Kitamura T Watanabe K Kawamori T Maruyama T Sugimoto Y Negishi M Narumiya S Sugimura T Wakabayashi K: Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut 2004, 53(8):1151-1158. 1774140 15247185 10.1136/gut.2003.028787
22. Grasa L Arruebo MP Plaza MA Murillo MD: PGE(2) receptors and their intracellular mechanisms in rabbit small intestine. Prostaglandins Other Lipid Mediat 2006, 79(3-4):206-217. 10.1016/j.prostaglandins.2006.01.001 16647635
23. Matlhagela K Taub M: Involvement of EP1 and EP2 receptors in the regulation of the Na, K-ATPase by prostaglandins in MDCK cells. Prostaglandins Other Lipid Mediat 2006, 79(1-2):101-113. 1892594 16516814 10.1016/j.prostaglandins.2005.12.002
24. Narumiya S SugimSto Y Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79(4):1193-1226. 10508233
25. Davies SP Reddy H Caivano M Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000, 351:95-105. 1221339 10998351 10.1042/0264-6021:3510095
26. Klingler C Kniesel U Bamforth SD Wolburg H Engelhardt B Risau W: Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors. Histochem Cell Biol 2000, 113:349-361. 10883394
27. Blanco-Aparicio C Torres J Pulido R: A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J Cell Biol 1999, 147:1129-1136. 2168101 10601328 10.1083/jcb.147.6.1129
28. Fujibe M Chiba H Kojima T Soma T Wada T Yamachita T Sawada N: Thr203 of claudin-1, a putative phosphorylation site for MAP Kinase, is required to promote the barrier function of tight junctions. Exp Cell Res 2004, 295:36-47. 10.1016/j.yexcr.2003.12.014 15051488
29. Hull MA Ko SC HawcroftTG: Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?. Mol Cancer Ther 2004, 3(8):1031-1039. 15299086
30. D' Souza T Indig FE Morin PJ: Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells. Exp Cell Res 2007, 313(15):3364-3375. 2034282 17678893 10.1016/ j.yexcr.2007.06.026
31. Yuki T Haratake A Koishikawa H Morita K Miyachi Y Inoue S: Tight junction proteins in keratinocytes: Localization and contribution to barrier function. Exp Dermatol 2007, 16(4):324-330. 10.1111/ j.1600-0625.2006.00539.x 17359339
32. Musch MW Walsh-Reitz MM Chang EB: Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption. Am J Physiol Gastrointest Liver Physiol 2006, 290(2):G222-231. 10.1152/ajpgi.00301.2005 16239402
33. Han X Fink MP Delude RL: Proinflammatory cytokines cause no dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003, 19:229-237. 10.1097/ 00024382-200303000-00006 12630522
34. Patrick DM Leone AK Shellenberger JJ Dudowicz KA King JM: Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 2006, 6(2):1-15. 1382248 16420690
35. Martin-Venegas R Roig-Perez S Ferrer R Moreno JJ: Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation. J Lipid Res 2006, 47(7):1416-1423. 10.1194/ jlr.M500564-JLR200 16585783
36. Furuse M Hata M Furuse K Yoshida Y Haratake A Sugitani Y Noda T Kubo A e Tsukita S: Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J Cell Biol 2002, 156:1099-1011. 2173463 11889141 10.1083/jcb.200110122
37. Meyer zum Büschenfelde D Tauber R Huber O: TFF3-peptide increases transepithelial resistance in epithelial cells by modulating claudin-1 and -2 expression. Peptides 2006, 27(12):3383-3390. 10.1016/ j.peptides.2006.08.020 17018241
38. Banan A Zhang LJ Shaikh M Fields JZ Choudhary S Forsyth CB Farhadi A Keshavarzian A: Theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: A novel mechanism for regulation of permeability. J Pharmacol Exp Ther 2005, 313(3):962-982. 10.1124/jpet.105.083428 15900076
39. Matlhagela K Taub M: Involvement of EP1 and EP2 receptors in the regulation of the Na, K-ATPase by prostaglandins in MDCK cells. Prostaglandins Other Lipid Mediat 2006, 79(1-2):101-113. 1892594 16516814 10.1016/j.prostaglandins.2005.12.002
40. Narumiya S SugimSto Y Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79(4):1193-1226. 10508233
41. Fujino H Regan JW: Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 2003, 278:12151-12156. 10.1074/jbc.M212665200 12566441
42. Tang CH Yang RS Fu WM: Prostaglandin E2 stimulates fibronectin expression through EP1 receptor, phospholipase C, protein kinase C-alpha, and c-Src pathway in primary cultured rat osteoblasts. J Biol Chem 2005, 280(24):22907-22916. 10.1074/jbc.M500130200 15833739
43. Nishihara H Hwang M Kizaka-Kondoh S Eckmann L Insel PA: Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J Biol Chem 2004, 279(25):26176-26183. 10.1074/jbc.M313346200 15078890
44. Castellone MD Teramoto H Williams BO Druey KM Gutkind JS: Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005, 310(5753):1504-1510. 10.1126/ science.1116221 16293724
45. Misra UK Pizzo SV: Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: Effects of silencing CREB gene expression on Akt activation. J Biol Che 2005, 280(46):38276-38289. 10.1074/jbc.M507332200
46. Whittard JD Akiyama SK: Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A. J Cell Sci 2001, 114(18):3265-3272 11591815
47. Towbin H Staehelin T Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979, 76:4350-4354. 411572 388439 10.1073/pnas.76.9.4350